Global Amniotic Band Syndrome Market, By Symptoms Type (Amnion Rupture Sequence, Amniotic Deformity, Adhesions, Mutilations (ADAM) Complex, Streeter Dysplasia and Others), Diagnosis Type (Targeted Ultrasound, Amniocentesis, Foetal echocardiogram and Others), Therapy Type (Supportive Therapies, Physical Therapy, Occupational Therapy and Others), Treatment Type (Prosthesis, Foetal Surgery, Reconstructive Surgery and Others), End Users (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy and Others) – Industry Trends and Forecast to 2030.
Amniotic Band Syndrome Market Analysis and Size
Global amniotic band syndrome market has experienced significant growth due to the advancements in prenatal imaging and diagnosis is one of the driving factors for the global amniotic band syndrome market. However, it's important to note that ABS is an extremely rare condition, affecting approximately 1 in 10,000 live births. Therefore, the market size is influenced by the prevalence of ABS cases.
Data Bridge Market Research analyses that the global amniotic band syndrome market which was USD 114.12 million in 2022, is expected to reach USD 334.12 million by 2030, and is expected to undergo a CAGR of 4.30% during the forecast period of 2023 to 2030. “Amnion Rupture Sequence” dominates the symptom type segment of the global amniotic band syndrome market due to advancements in prenatal imaging and diagnosis. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Amniotic Band Syndrome Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Symptoms Type (Amnion Rupture Sequence, Amniotic Deformity, Adhesions, Mutilations (ADAM) Complex, Streeter Dysplasia and Others), Diagnosis Type (Targeted Ultrasound, Amniocentesis, Foetal echocardiogram and Others), Therapy Type (Supportive Therapies, Physical Therapy, Occupational Therapy and Others), Treatment Type (Prosthesis, Foetal Surgery, Reconstructive Surgery and Others), End-Users (Hospitals, Homecare, Specialty Clinics and Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy and Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
GSK plc. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Astrazeneca (U.S.), Pfizer Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Sanofi (U.S.), Amgen Inc. (U.S.), Daiichi Sankyo Company Limited (Japan), AB Sciences (France), Eisai Co., Ltd (Japan), Genentech Inc. (U.S), Merck & Co., Inc. (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Amniotic band syndrome (ABS) comprises various congenital anomalies, which include disruption, deformation, and malformations of organs that were intended to develop normally. Amniotic band syndrome should be called a sequence rather than a syndrome because the pattern of anomalies in ABS are related to an insult that can result from multiple etiologies, whereas a syndrome refers to patterns of congenital anomalies that are known to result from single etiology (for instance, Turner syndrome is due to XO chromosomal anomaly). Likewise, ABS has many names amnion rupture sequence, ADAM complex (amniotic deformities/adhesions/mutilations), amniotic band disruption complex, congenital constricting bands, terminal transverse defects, and Streeter anomaly.
Global Amniotic Band Syndrome Market Dynamics
Drivers
- Advancements in Prenatal Imaging and Diagnosis
Advances in prenatal imaging and diagnostic technologies have played a pivotal role in driving the ABS market. High-resolution ultrasound, magnetic resonance imaging (MRI), and genetic testing have improved the early detection and diagnosis of ABS during pregnancy. These advanced imaging modalities allow healthcare professionals to identify signs of ABS-related complications, such as amniotic bands constricting fetal limbs or organs, at an earlier stage. As a result, expectant parents and healthcare providers can make informed decisions about prenatal care and potential interventions. This early diagnosis contributes to increased demand for ABS-related medical products and services, driving the market's growth
- Growing Awareness and Education
A significant driver for the ABS market is the growing awareness and education about this rare congenital condition. Healthcare professionals, including obstetricians and pediatricians, have become increasingly aware of ABS and its potential impact on fetal development. Additionally, expectant parents are now more informed about the condition, thanks to improved access to medical information and prenatal resources. As a result, there is a greater likelihood of early diagnosis and timely interventions. The heightened awareness and education efforts have expanded the market for ABS-related products and services as more individuals seek appropriate medical care
- Innovations in Surgical Techniques
Innovations in surgical techniques have positively influenced the ABS market, particularly in addressing limb and organ deformities. Microsurgery, minimally invasive procedures, and advances in reconstructive techniques have improved surgical outcomes for individuals with ABS-related limb anomalies. These innovations not only enhance the effectiveness of surgical interventions but also contribute to shorter recovery times and improved quality of life for patients. Consequently, the demand for specialized surgical services for ABS has increased, fostering market growth
Opportunities
- Adoption of Telemedicine and Telehealth
The growing adoption of telemedicine and telehealth solutions presents an opportunity to expand access to medical consultations and support services for individuals with ABS, especially in remote or underserved areas. Telehealth platforms can facilitate consultations with specialized healthcare providers, offer guidance on prenatal care, and provide psychological support for affected individuals and their families. The convenience and accessibility of telemedicine can enhance the overall care experience for those with ABS
- Patient Advocacy and Support Groups
Patient advocacy organizations and support groups dedicated to ABS can play a vital role in advancing the market. These organizations advocate for increased awareness, fund research initiatives, and provide support services to individuals and families affected by ABS. Collaboration with patient advocacy groups can enhance patient care, provide valuable insights for research and development efforts, and foster a sense of community among those impacted by ABS
Restraints/Challenges
- High Cost of Treatment
The high cost associated with ABS-related treatment is a notable restraint, affecting both individuals and healthcare systems. Surgical procedures, ongoing medical care, and rehabilitative therapies can be financially burdensome for affected families. Insurance coverage for ABS-related treatments may also be limited or subject to restrictions. The high cost of treatment can lead to delays in seeking medical care and interventions, particularly for individuals without adequate financial resources or insurance coverage
-
Access to Specialized Care
Access to specialized medical care for ABS-related interventions may be limited in certain regions. This challenge leads to disparities in treatment outcomes, with some individuals facing difficulties in accessing expert surgical and medical services. Addressing disparities in care and improving access to specialized healthcare providers remains a challenge for the ABS market
This global amniotic band syndrome market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global amniotic band syndrome market Contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth
Recent Development
- In December 20202, According to the National Library of Medicine, the estimated incidence of amniotic band syndrome ranged between 1 in 1000 to 1 in 15000 live births and 1 in 70 stillbirths
Global Amniotic Band Syndrome Market Scope
The global amniotic band syndrome market is segmented on the basis of symptoms type, diagnosis type, therapy type, treatment type, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Symptoms Type
- Amnion Rupture Sequence
- Amniotic Deformity
- Adhesions
- Mutilations (ADAM) Complex
- Streeter Dysplasia
- Others
Diagnosis Type
- Targeted Ultrasound
- Amniocentesis
- Foetal echocardiogram
- Others
Therapy Type
- Supportive Therapies
- Physical Therapy
- Occupational Therapy
- Others
Treatment Type
- Prosthesis
- Foetal Surgery
- Reconstructive Surgery
- Others
End-Users
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Global Amniotic Band Syndrome Market Regional Analysis/Insights
The global amniotic band syndrome market is analyzed and market size insights and trends are provided by symptoms type, diagnosis type, therapy type, treatment type, end-users and distribution channel as referenced above.
The countries covered in the global amniotic band syndrome market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
North America dominates the global amniotic band syndrome market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is because of the increase in the expenditure for research and development proficiencies, increasing government’s initiatives and improved health care infrastructure in various countries.
Asia-Pacific on the other hand, is projected to exhibit the highest growth rate in the global amniotic band syndrome market during the forecast period of 2023 to 2030 owing to the increasing government expenditure on the healthcare sector and rising technological advancements and initiatives by the government.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Amniotic Band Syndrome Market Share Analysis
The global amniotic band syndrome market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company’s focus related to global amniotic band syndrome market.
Some of the major players operating in the global amniotic band syndrome market are:
- GSK plc. (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Novartis AG (Switzerland)
- Astrazeneca (U.S.)
- Pfizer Inc. (U.S.)
- Bristol-Myers Squibb Company (U.S.)
- Sanofi (U.S.)
- Amgen Inc. (U.S.)
- Daiichi Sankyo Company Limited (Japan)
- AB Sciences (France)
- Eisai Co., Ltd (Japan)
- Genentech Inc. (U.S)
- Merck & Co., Inc. (U.S.)
SKU-